TCT-416 In vivo assessment of endothelial-dependent vasomotion in a coronary segment treated by the Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial.
Citation: Journal of the American College of Cardiology. 68(18S):B168, 2016 Nov 01PMID: 27969766Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2016Local holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007ISSN:- 0735-1097
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 27969766 | Available | 27969766 |
Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007
English